In Ewing sarcoma, however, EWS/FLI displays a “gain-of-function” in its ability to also bind ‘GGAA’-containing microsatellite (repeat) regions to regulate some of its targets, such as key oncogenic target NR0B1 [8,9]. The gene discussed is EWSR1; the disease is Ewing sarcoma.